In this study, we conducted a large-scale bioinformatic analysis of the genetic and clinicopathologic data of patients with colon cancer and revealed that PBK/TOPK could act as a favorable prognostic biomarker in colon cancer. Here, PBK is linked to colonic neoplasm.